Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer

Heparin‐induced thrombocytopenia (HIT) is a serious adverse reaction to heparin treatment with a high risk of thrombosis. Heparin must be discontinued immediately and replaced with alternative anticoagulants that do not interact with HIT antibodies. In this case, a lung cancer patient, diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Pia Bükmann, Jørgensen, Maja, Friis‐Hansen, Lennart, Ingeberg, Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693689/
https://www.ncbi.nlm.nih.gov/pubmed/26732728
http://dx.doi.org/10.1002/ccr3.411
_version_ 1782407413720154112
author Larsen, Pia Bükmann
Jørgensen, Maja
Friis‐Hansen, Lennart
Ingeberg, Steen
author_facet Larsen, Pia Bükmann
Jørgensen, Maja
Friis‐Hansen, Lennart
Ingeberg, Steen
author_sort Larsen, Pia Bükmann
collection PubMed
description Heparin‐induced thrombocytopenia (HIT) is a serious adverse reaction to heparin treatment with a high risk of thrombosis. Heparin must be discontinued immediately and replaced with alternative anticoagulants that do not interact with HIT antibodies. In this case, a lung cancer patient, diagnosed with HIT was successfully treated with apixaban.
format Online
Article
Text
id pubmed-4693689
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-46936892016-01-05 Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer Larsen, Pia Bükmann Jørgensen, Maja Friis‐Hansen, Lennart Ingeberg, Steen Clin Case Rep Case Reports Heparin‐induced thrombocytopenia (HIT) is a serious adverse reaction to heparin treatment with a high risk of thrombosis. Heparin must be discontinued immediately and replaced with alternative anticoagulants that do not interact with HIT antibodies. In this case, a lung cancer patient, diagnosed with HIT was successfully treated with apixaban. John Wiley and Sons Inc. 2015-10-29 /pmc/articles/PMC4693689/ /pubmed/26732728 http://dx.doi.org/10.1002/ccr3.411 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Larsen, Pia Bükmann
Jørgensen, Maja
Friis‐Hansen, Lennart
Ingeberg, Steen
Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
title Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
title_full Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
title_fullStr Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
title_full_unstemmed Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
title_short Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
title_sort apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693689/
https://www.ncbi.nlm.nih.gov/pubmed/26732728
http://dx.doi.org/10.1002/ccr3.411
work_keys_str_mv AT larsenpiabukmann apixabanusedforthemanagementofheparininducedthrombocytopeniaina72yearoldwomanwithlungcancer
AT jørgensenmaja apixabanusedforthemanagementofheparininducedthrombocytopeniaina72yearoldwomanwithlungcancer
AT friishansenlennart apixabanusedforthemanagementofheparininducedthrombocytopeniaina72yearoldwomanwithlungcancer
AT ingebergsteen apixabanusedforthemanagementofheparininducedthrombocytopeniaina72yearoldwomanwithlungcancer

Ejemplares similares